Subcellular Targeting of p33^ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21^WAF1 Expression

REFERENCES

• Aitken, A. 2002. Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol. Biol. 50:993–1010.
   PubMed Web of Science ®Google Scholar
• Atadja, P. W., K. F. Stringer, and K. T. Riabowol. 1994. Loss of serum response element-binding activity and hyperphosphorylation of serum response factor during cellular aging. Mol. Cell. Biol. 14:4991–4999.
   PubMedGoogle Scholar
• Bean, L. J., and G. R. Stark. 2001. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene 20:1076–1084.
   PubMedGoogle Scholar
• Berardi, P., S. Pastyryeva, P. Bonnefin, X. Feng, K. Suzuk, A. Colina, D. Young, and K. Riabowol. Submitted for publication.
   Google Scholar
• Boland, D., V. Olineck, P. Bonnefin, D. Vieyra, E. Parr, and K. Riabowol. 2000. A panel of CAb antibodies recognizes endogenous and ectopically expressed ING1 protein. Hybridoma 19:161–165.
   PubMedGoogle Scholar
• Brunet, A., F. Kanai, J. Stehn, J. Xu, D. Sarbassova, J. V. Frangioni, S. N. Dalal, J. A. DeCaprio, M. E. Greenberg, and M. B. Yaffe. 2002. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156:817–828.
   PubMed Web of Science ®Google Scholar
• Chen, L., N. Matsubara, T. Yoshino, T. Nagasaka, N. Hoshizima, Y. Shirakawa, Y. Naomoto, I. H. Isozak, K. Riabowol, and N. Tanaka. 2001. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res. 61:4345–4349.
   PubMedGoogle Scholar
• Cheung, K. J., Jr., D. Mitchell, P. Lin., and G. Li. 2001. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res. 61:4974–4977.
   PubMedGoogle Scholar
• Cheung, K. J., Jr., and G. Li. 2002. p33(ING1) enhances UVB-induced apoptosis in melanoma cells. Exp. Cell Res. 279:291–298.
   PubMedGoogle Scholar
• Feng, X., Y. Hara, and K. Riabowol. 2002. Different HATS of the ING1 gene family. Trends Cell Biol. 12:532–538.
   PubMed Web of Science ®Google Scholar
• Ford, J. C., F. al-Khodairy, E. Fotou, K. S. Sheldrick, D. J. Griffiths, and A. M. Carr. 1994. 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. Science 265:533–535.
   PubMed Web of Science ®Google Scholar
• Fu, H., R. R. Subramanian, and S. C. Masters. 2000. 14-3-3 proteins: structure, function, and regulation, Annu. Rev. Pharmacol. Toxicol. 40:617–647.
   PubMed Web of Science ®Google Scholar
• Fujita, N., S. Sato, K. Katayama, and T. Tsuruo. 2002. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277:28706–28713.
   PubMedGoogle Scholar
• Garkavtsev, I., A. Kazarov, A. Gudkov, and K. Riabowol. 1996. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14:415–420.
   PubMedGoogle Scholar
• Garkavtsev, I., I. A. Grigorian, V. S. Ossovskaya, M. V. Chernov, P. M. Chumakov, and A. V. Gudkov. 1998. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391:295–298.
   PubMed Web of Science ®Google Scholar
• Garkavtsev, I., S. V. Kozin, O. Chernova, L. Xu, F. Winkle, E. Brown, G. H. Barnett, and R. K. Jain. 2004. The candidate tumor suppressor protein ING4 regulates brain tumor growth and angiogenesis. Nature 428:328–332.
   PubMed Web of Science ®Google Scholar
• Garkavtsev, I., D. Demetrick, and K. Riabowol. 1997. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet. Cell Genet. 76:176–178.
   PubMedGoogle Scholar
• Gozani, O., P. Karuman, D. R. Jones, D. Ivanov, J. Cha, A. A. Lugovskoy, C. L. Baird, H. Zhu, S. J. Field, S. L. Lessnick, J. Villasenor, B. Mehrotra, J. Chen, V. R. Rao, J. S. Brugge, C. G. Ferguson, B. Payrastre, D. G. Myszka, L. C. Cantley, G. Wagner, N. Divecha, G. D. Prestwich, and J. Yuan. 2003. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114:99–111.
   PubMed Web of Science ®Google Scholar
• Guangan, He., Z. H. Siddik, Z. Huang, R. Wang, J. Koomen, R. Kobayashi, A. R. Khokhar, and J. Kuang. 2005. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24:2929–2943.
   PubMedGoogle Scholar
• He, G. H., C. C. Helbing, M. J. Wagner, C. W. Sensen, and K. Riabowol. 2005. Phylogenetic analysis of the ING family of PHD finger proteins. Mol. Biol. Evol. 22:104–116.
   PubMed Web of Science ®Google Scholar
• Helbing, C. C., C. Veillette, K. Riabowol, R. N. Johnston, and I. Garkavtsev. 1997. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res. 57:1255–1258.
   PubMed Web of Science ®Google Scholar
• Hermeking, H., C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, K. W. Kinzler, and B. Vogelstein. 1997. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3–11.
   PubMed Web of Science ®Google Scholar
• Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59.
   PubMed Web of Science ®Google Scholar
• Ito, K., K. Kinjo, T. Nakazato, Y. Ikeda, and M. Kizaki. 2002. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia. Am. J. Hematol. 69:141–143.
   PubMedGoogle Scholar
• Jiang, K., E. Pereira, M. Maxfield, B. Russell, D. M. Goudelock, and Y. Sanchez. 2003. Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J Biol. Chem. 278:25207–25217.
   PubMed Web of Science ®Google Scholar
• Kameyama, K., C. L. Huang, D. Liu, D. Masuya, T. Nakashima, S. Sumitomo, Y. Takami, M. Kinoshita, and H. Yokomise. 2003. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Clin. Cancer Res. 9:4926–4934.
   PubMedGoogle Scholar
• Kataoka, H., Bonnefin. P, D. Vieyra, X. Feng, Y. Hara, Y. Miura, T. Joh, H. Nakabayashi, H. Vaziri, C. C. Harris, and K. Riabowol. 2003. ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res. 63:5785–5792.
   PubMedGoogle Scholar
• Leung, K. M., L. S. Po, F. C. Tsang, W. Y. Siu, A. Lau, H. T. Ho, and R. Y. C. Poon. 2002. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res. 62:4890–4893.
   PubMedGoogle Scholar
• Loewith, R., M. Meijer, S. P. Lees-Miller, K. Riabowol, and D. Young. 2000. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol. Cell. Biol. 20:3807–3816.
   PubMed Web of Science ®Google Scholar
• Lottersberger, F., F. Rubert, V. Baldo, G. Lucchini, and M. P. Longhese. 2003. Functions of Saccharomyces cerevisiae 14-3-3 proteins in response to DNA damage and to DNA replication stress. Genetics 165:1717–1732.
   PubMedGoogle Scholar
• Ma, D., D. Lawless, and K. Riabowol. 1999. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 23:373.
   PubMedGoogle Scholar
• Mackintosh, C. 2004. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381:329–342.
   PubMedGoogle Scholar
• Maestro, R., S. Piccinin, C. Doglioni, D. Gasparotto, C. T. Vukosavljevi, S. Sulfaro, L. Barzan, and M. Boiocchi. 1996. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res. 56:1146–1150.
   PubMedGoogle Scholar
• Muslin, A. J., J. W. Tanner, P. M. Allen, and A. S. Shaw. 1996. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889–897.
   PubMed Web of Science ®Google Scholar
• Nguyen, A., D. M. Rothman, J. Stehn, B. Imperiali, and M. B. Yaffe. 2004. Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint function. Nat. Biotechnol. 22:993–1000.
   PubMed Web of Science ®Google Scholar
• Nouman, G. S., J. J. Anderson, K. M. Wood, J. Lunec, A. G. Hall, M. M. Reid, and B. Angus. 2002. Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J. Clin. Pathol. 55:596–601.
   PubMedGoogle Scholar
• Oki, E., Y. Maehara, E. Tokunaga, Y. Kakeji, and K. Sugimachi. 1999. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett. 147:157–162.
   PubMedGoogle Scholar
• Powell, D. W., M. J. Rane, Q. Chen, S. Singh, and K. R. McLeish. 2002. Identification of 14-3-3zeta as a protein kinase B/Akt substrate. J. Biol. Chem. 277:21639–21642.
   PubMed Web of Science ®Google Scholar
• Sager, R. 1997. Expression genetics in cancer: Shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA 94:952–955.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, p. 16.30-16.73, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Sato, S., N. Fujita, and T. Tsuruo. 2002. Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. J. Biol. Chem. 277:39360–39367.
   PubMedGoogle Scholar
• Scott, M., P. Bonnefin, D. Vieyra, F. M. Boisvert, D. Young, D. P. Bazett-Jones, and K. Riabowol. 2001. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J. Cell Sci. 114:3455–3462.
   PubMed Web of Science ®Google Scholar
• Scott, M., F. M. Boisvert, D. Vieyra, R. N. Johnston, D. P. Bazett-Jones, and K. Riabowol. 2001. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic Acids Res. 29:2052–2058.
   PubMedGoogle Scholar
• Shinoura, N., Y. Muramatsu, M. Nishimura, Y. Yoshida, A. Saito, T. Yokoyama, T. Furukawa, A. Horii, M. Hashimoto, A. Asai, T. Kirino, and H. Hamada. 1999. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res. 59:5521–5528.
   PubMed Web of Science ®Google Scholar
• Skowyra, D., M. Zeremski, N. Neznanov, M. Li, Y. Choi, M. Uesugi, C. A. Hauser, W. Gu, A. V. Gudkov, and J. Qin. 2001. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J. Biol. Chem. 276:8734–8739.
   PubMedGoogle Scholar
• Tallen, G., K. Riabowol, and J. E. Wolff. 2003. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells. Anticancer Res. 23:1631–1635.
   PubMedGoogle Scholar
• Toyama, T., H. Iwase, P. Watson, H. Muzik, E. Saettler, A. Magliocco, L. DiFrancesco, P. Forsyth, I. Garkavtsev, S. Kobayashi, and K. Riabowol. 1999. Suppression of ING1 expression in sporadic breast cancer. Oncogene 18:5187–5193.
   PubMedGoogle Scholar
• Tsang, Y. S., K. W. Lo, S. F. Leung, P. H. Choi, Y. Fong, J. C. Lee, and D. P. Huang. 1999. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int. J. Cancer 83:305–308.
   PubMedGoogle Scholar
• Uchida, S., A. Kuma, M. Ohtsubo, M. Shimura, M. Hirata, H. Nakagama, T. Matsunaga, Y. Ishizaka, and K. Yamashita. 2004. Binding of 14-3-3beta but not 14-3-3sigma controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B. J. Cell Sci. 117:3011–3020.
   PubMedGoogle Scholar
• Vieyra, D., R. Loewith, M. Scott, P. Bonnefin, F. M. Boisvert, P. Cheema, S. Pastyryeva, M. Meijer, R. N. Johnston, D. P. Bazett-Jones, S. McMahon, M. D. Cole, D. Young, and K. Riabowol. 2002. Human ING1 proteins differentially regulate histone acetylation. J. Biol. Chem. 277:29832–29839.
   PubMed Web of Science ®Google Scholar
• Vieyra, D., T. Toyama, Y. Hara, D. Boland, R. Johnston, and K. Riabowol. 2002. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res. 62:4445–4452.
   PubMedGoogle Scholar
• Vieyra, D., D. L. Senger, T. Toyama, H. Muzik, P. M. Brasher, R. N. Johnston, K. Riabowol, and P. A. Forsyth. 2003. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Clin. Cancer Res. 9:5952–5961.
   PubMedGoogle Scholar
• Waterman, M. J., E. S. Stavridi, J. L. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175–178.
   PubMed Web of Science ®Google Scholar
• Yaffe, M. B., K. Rittinger, S. Volinia, P. R. Caron, A. Aitken, H. Leffers, S. J. Gamblin, S. J. Smerdon, and L. C. Cantley. 1997. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91:961–971.
   PubMed Web of Science ®Google Scholar
• Yaffe, M. B. 2002. How do 14-3-3 proteins work?- Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513:53–57.
   PubMed Web of Science ®Google Scholar